Skip to main content
. 2022 Apr 15;12(4):1606–1620.

Table 4.

Treatment-related adverse events

Adverse events Any grade Grade 3 Grade 4 Grade 5
Dermatitis 24 (83) 1 (3) 0 0
Anemia 15 (52) 1 (3) 0 0
Anorexia or nausea 14 (48) 0 0 0
Thrombocytopenia 9 (31) 1 (3) 0 0
Aspartate aminotransferase increased 7 (24) 3 (10) 0 0
Leukopenia/Neutropenia 7 (24) 1 (3) 0 0
Alanine aminotransferase increased 6 (21) 2 (7) 0 0
Gastrointestinal bleeding 5 (17) 4 (14) 0 0
Blood bilirubin increased 5 (17) 1 (3) 1 (3) 0
Fatigue 5 (17) 0 0 0
Pneumonitis 4 (14) 0 0 0
Diarrhea 3 (10) 0 0 0
Hepatic failure 2 (7) 0 0 2 (7)
Alkaline phosphatase increased 2 (7) 0 0 0
Duodenal perforation 1 (3) 0 0 1 (3)
Biliary stricture 1 (3) 0 1 (3) 0
Biliary tract infection 1 (3) 1 (3) 0 0
Lung infection 1 (3) 1 (3) 0 0
Skin infection 1 (3) 0 0 0